$AME

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

Original reporting
Published Nov 3, 2026, 12:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 5:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMETEK Boosts FY26 Outlook - Update — source image
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

The guidance raise changes the earnings trajectory for 2026 and can drive revisions to consensus estimates, positioning, and valuation for AME.

02

Market read

Traders can update AME’s earnings expectations immediately based on the new Q4 and FY2026 EPS ranges and the raised prior outlook.

03

What to watch

Investors may focus on whether the low-20% Q4 net sales growth and mid-teen FY2026 growth assumptions are sustainable, and how much of the EPS lift depends on Indicor integration.

Relevance 8/10Novelty 8/10Timing: pre-market today, after AMETEK’s Q3 results and guidance update

Background

AMETEK reported Q3 results and updated Q4 and full-year 2026 adjusted earnings and net sales growth guidance, explicitly referencing Indicor Instrumentation’s expected contribution.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK raised FY2026 adjusted earnings outlook to $8.53-$8.57 and guided Q4 EPS $2.26-$2.30, citing strong Q3 and Indicor contribution.

Expected impact

Likely upward bias as traders reprice FY2026 earnings power and the expected Indicor Instrumentation contribution.

Evidence & confidence

The article provides specific, higher FY2026 EPS and Q4 EPS ranges versus the prior outlook, which is a direct repricing catalyst.

Market effects

Signals strength in industrial solutions demand and acquisition-driven earnings contributions, supportive for industrial peers with similar end-markets.

Primarily US industrials sentiment, with limited direct regional spillover beyond industrial value chains.

Indicor-related guidance may modestly affect global industrial instrumentation sentiment, but impact is company-specific.

Counterpoint

The raised outlook may be partially acquisition-driven, so organic growth durability could be questioned by traders.

Key entities

  • AMETEK, Inc.

    Industrial solutions provider issuing Q4 and FY2026 adjusted earnings guidance update, citing strong Q3 and Indicor Instrumentation contribution.

  • Indicor Instrumentation

    Acquired business expected to contribute to AMETEK’s FY2026 results, referenced as a driver of the outlook raise.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.

$AMEMedAI 9/10

Ametek: Q3 Earnings Snapshot

Ametek Inc. (AME) reported Q3 net income of $426.3M, or $1.85 per share, beating estimates. Revenue was $2.22B, also surpassing forecasts. The company projects Q4 EPS of $2.26-$2.30 and full-year EPS of $8.53-$8.57. Shares are up 18% YTD and 20% over 12 months.